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Abstract
Introduction: Blastocystis hominis in stool samples of individuals with allergic cutaneous symptoms were 
evaluated to study a possible link between them. 
Methods: The study was done from June 2010 to December 2011, in dermatology and parasitology depart-
ment of central laboratory, Alnoor Specialist Hospital, Ministry of Health, Makkah, Saudi Arabia. A total of 
218 stool sample for patients who attended dermatology clinic and diagnosed as chronic urticaria, atopic 
dermatitis, or pruritus of unknown origin were included in the study. Standard laboratory tests for the detec-
tion of allergic etiology were performed for all patients. Detection of Blastocystis hominis has been made by 
microscopic examination of stool samples by direct examination and concentration technique. 
Results: Overall, 30(13.7%) stool samples were infected by Blastocystis hominis with age group (26-35) and 
male predominace 15(6.9%) and 18(8.2%), respectively. No other allergic cause of urticaria was discovered.
Conclusion: Blastocystis hominis could be the etiology of chronic urticaria. © 2012 All rights reserved
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Introduction
Blastocystis hominis (B. hominis) is an enteric para-
site which has long been considered as an innocu-
ous commensal living in the intestinal tract and is 
still the subject of controversy regarding its patho-
genicity and possibly opportunistic character (1,2). 
Urticaria is a common and frequently debilitating 
disease (3). Etiologic grounds of acute urticaria 
are generally identified, but remained unknown 
in most of the chronic cases. The studies on the 
roles of parasitic infections in the etiology of ur-
ticaria have indicated that the most responsible 
protozoa are Giardia intestinalis and B. hominis (4).
The presence of urticaria associated with B. homi-
nis infection has been described in very few 
studies (5). Extra-intestinal manifestations of 
B. hominis infection have rarely been reported 
and include skin disorders such as palmoplantar 
or diffuse pruritus and chronic urticaria (6-9).
A large number of parasites have been cor-
related with urticaria but few data exist as re-
gards B. hominis infection. Considering that B. 
hominis is a modest pathogen for humans, the 
mechanism is probably the typical one of cu-
taneous allergic hypersensitivity; antigen para-
sites induce the activation of specific clones of 
Th2 lymphocytes, the release of related cyto-
kines and the consequent IgE production (10).
Our study revealed the presence of B. homi-
nis infection in patients of chronic urticaria.
Methods
The study was done from June 2010 to De-
cember 2011, with the collaboration of derma-
tology department and parasitology depart-
ment of central laboratory, Alnoor Specialist 
Hospital, Ministry of Health, Makkah, Saudi 
Arabia. This hospital is a 550-bedded refer-
ral teaching hospital delivering tertiary care 
throughout the Makkah region of Saudi Arabia. 
During the study period the patients with age of 
(5-65 years) diagnosed as chronic urticaria, pru-
ritis of unknown origin, and atopic dermatitis 
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by dermatology department were included in 
the study. In addition to other laboratory inves-
tigations, stool specimens from each subject was 
collected in a clean stool cup by medical labora-
tory technicians and transported into labora-
tory. All stool examinations were performed 
by direct method and concentrated Techniques. 
Direct method was performed in the same way as 
described earlier (11,12). With the concentration 
technique using fecal parasite concentrator (FPC), 
three spoons of stool was added to 9 ml of 10% 
Formalin provided at the flat-bottom tube. The 
specimens were mixed thoroughly and allow 30 
minutes for fixation. Three drops of Triton were 
added to the mixed specimen followed by 3 ml 
of ethyl acetate. The FPC strainer was tightly at-
tached to the flat-bottomed tube containing the 
fecal specimen and shaken vigorously for 30 sec-
onds. Pointing the conical end downward; the 
specimen was shaken through the strainer into 
a 15 ml centrifuge tube. The FPC strainer was 
then unscrewed with the flat-bottomed tube still 
attached. The transport tube and strainer were 
discarded in an appropriate manner in biohazard 
bags. The 15 ml tube was capped and centrifuged 
at 500 x g for 10 minutes. After centrifugation, the 
specimen was clearly separated into four layers. 
The debris layer was rimmed using an applicator 
stick and the debris and supernatant fluid were 
poured out. With the tube still inverted, a cotton-
tipped applicator stick was used to clean and re-
move the remaining debris and ethyl acetate, and 
the tube was returned to an upright position and 
two to three drops of 5% or 10% formalin, saline 
were added and the sediment was mixed thor-
oughly. The slides were prepared with a transfer 
pipet, cover slip, and were examined using low 
(x10) and high (x40) power microscope (13).
The study protocol was approved by our institutional 
review board. Descriptive analysis was done by us-
ing Microsoft excel version 7 on personal computer.
Results
A total of 218 stool samples for patients diagnosed 
as chronic urticaria were subjected to direct and 
concentration methods and only 30 (13.7%) were 
found to be infected by B. hominis with male pre-
dominance 18 (8.2%). More frequent age group 
was 25-35 years, 15(6.9%). Laboratory investi-
gations failed to disclose any systemic diseases, 
including malabsorption, endocrinological, au-
toimmune and rheumatological disorders. Full 
blood count, including eosinophil count, eryth-
rocyte sedimentation rate, C-reactive protein, 
cryoglobulins, circulating immune complexes, 
C3, C4, C1-INH, IgE and other immunoglobu-
lins were all within the normal range. One stool 
sample of male patient aged 47 years old has 
long history of chronic urticaria showed positive 
results for three types of parasites, i.e., B. homi-
nis, Entameoba histolytica and Giardia lamblia.
Discussion
In our results we found 13.7% infected cases by B. 
hominis which was agreed with other studies in 
the perspective that B. hominis has some link with 
urticaria (2,5,6,10,14). A study from Switzerland 
Variables
total cases 
n=218
infected
 cases n=30
n n(%)
gender
Male 115 18(8.2)
female 103 12(5.5)
age groups 
in years
5-15 16 3(1.4)
16-25 45 4(1.8)
26-35 75 15(6.9)
36-45 73 6(2.8)
>45 9 2(0.9)
Table 1.  Demographical distribution of Blastocystis homi-
nins infection among allergic skin diseased patients
FIGURe 1.  Blastocystis hominins cyst-like in a wet mount 
stained in iodine (vacular form) 40x
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found parasites in stool in 35% of 46 patients with 
chronic urticaria, most of them with B. hominis 
(15). In one study 29.1% of the patients were found 
to have protozoan (B. hominis & G. intestinalis) in-
fections (16). Extra-intestinal manifestations of B. 
hominis infection have rarely been reported and 
included skin disorders such as palmoplantar or 
diffuse pruritus and chronic urticaria (6, 7, 8, 9).
In Taiwan, the association of clinical symptoms 
and B. hominis could not be delineated from study, 
even in immunocompromised patients. All of the 
patients improved without receiving any specific 
therapy (17). In contrast to our study, in Australia 
no correlation was found between clinical symp-
toms and B. hominis (18). In Japan and Canada, 
B. hominis positive individuals had no reported 
symptoms with B. hominis that proved no cor-
relation (19, 20). Thus, B. hominis, though com-
monly seen in stool samples submitted to this lab-
oratory, is thought to be a commensal organism. 
Thirty stool samples became positive after using 
both methods in our study, i.e., 28(93.6%) cases 
by direct method and 2 (6.7%) by concentration 
method. Our results agreed with a number of re-
ports indicated that the formol ethyl acetate con-
centration technique (FECT) have poor sensitivity 
than Lugols iodine staining for protozoal detection 
so it should be discouraged (21-23). Acute urti-
caria of unknown etiology and chronic idiopathic 
urticaria patients who are resistant to the ordinary 
regimen of urticaria treatment might be examined 
for infection with B. hominis, in order to prescribe 
the proper specific anti-protozoan treatment (24).
Conclusion
Protozoan should be considered in the etiology of 
chronic urticaria and stool examination should be 
done in these patients routinely especially by di-
rect method.
Competing interests
We declare that we have no financial or personal 
relationship(s) which may have inappropriately 
influenced us in writing this paper.
References
(1) Tai WP, Hu PJ, Wu J, Lin XC. Six 
ulcerative colitis patients with re-
fractory symptoms co-infective 
with Blastocystis hominis in China. 
Parasitol Res 2011;108(5):1207-10.
(2) Trabelsi S, Ali IB, Khaled S. Clinical 
and epidemiological characteristics 
of Blastocystis hominis. Tunis Med 
2010;88(3):190-2.
(3) Weller K, Viehmann K, Bräuti-
gam M, Krause K, Siebenhaar F, 
Zuberbier T, et al. Cost-intensive, 
time-consuming, problematical? 
How physicians in private practice 
experience the care of urticaria 
patients. J Dtsch Dermatol Ges 
2011 Nov; 23. doi: 10.1111/j.1610-
0387.2011.07822.x.
(4) Karaman U, Sener S, Calık S, 
Saşmaz S. Investigation of micro-
sporidia in patients with acute and 
chronic urticaria. Mikrobiyol Bul 
2011;45(1):168-73.
(5) Micheloud D, Jensen J, Fernandez-
Cruz E, Carbone J. Chronic an-
gioedema and Blastocystis hominis 
infection. Rev Gastroenterol Peru 
2007;27(2):191-3.
(6) Armentia A, Méndez J, Gómez 
A, Sanchís E, Fernández A, de la 
Fuente R, et al. Urticaria by Blas-
tocystis hominis. Allergol Immuno-
pathol (Madr) 1993;21(4):149-51.
(7) Kick G, Rueff F, Przybilla B. Pal-
moplantar pruritus subsiding after 
Blastocystis hominis eradication. 
Acta Derm Venereol 2002;82(1):60.
(8) Biedermann T, Hartmann K, Sing 
A, Przybilla B. Hypersensitivity to 
non-steroidal anti-inflammato-
ry drugs and chronic urticaria 
cured by treatment of Blastocystis 
hominis infection. Br J Dermatol 
2002;146(6):1113-1114.
(9) Valsecchi R, Leghissa P, Greco V. 
Cutaneous lesions in Blastocystis 
hominis infection. Acta Derm Ve-
nereol 2004;84(4):322-323.
(10) Pasqui AL, Savini E, Saletti M, Guz-
zo C, Puccetti L, Auteri A. Chronic 
urticaria and Blastocystis hominis 
infection: a case report. Eur Rev 
Med Pharmacol Sci 2004;8(3):117-
20.
(11) Garcia LS. Diagnostic medical par-
asitology, 4th ed. ASM press, Wash-
ington, DC 2001. p. 723.
(12) Zaglool DAM, Khudri YAW, Gaz-
zaz ZJ, Dhafar KO, Shaker HA, 
Farooq MU. Prevalence of intes-
tinal parasites among patients 
of Alnoor Specialist Hospital, 
Makkah, Saudi Arabia. Oman Med 
J 2011;26(3):183-186. 
(13) Evergreen industries, Inc., 1992. Fe-
cal parasite concentrator, 2300 East 
49 TH street Los angeles, FAX(213) 
581-2503.
(14) Gupta R, Parsi K. Chronic urticaria 
due to Blastocystis hominis. Austra-
las J Dermatol 2006;47(2):117-9.
(15) Trachsel C, Pichler WJ, Helbling A. 
Importance of laboratory investiga-
tions and trigger factors in chronic 
urticaria. Schweiz Med Wochen-
schr 1999;129(36):1271-9.
(16) Doğruman Al F, Adişen E, 
Kuştimur S, Gürer MA. The role 
of protozoan parasites in etiology 
of urticaria. Turkiye Parazitol Derg 
2009;33(2):136-9.
(17) Kuo HY, Chiang DH, Wang CC, 
Chen TL, Fung CP, Lin CP, et al. 
Clinical significance of Blasto-
cystis hominis: experience from 
a medical center innorthern Tai-
wan. J Microbiol Immunol Infect 
69Journal of HealtH ScienceS 2012; 2 (1)
Dina aBDulla MuHaMMaD Zaglool et al.: BlaStocyStiS HoMiniS anD allergic SKin DiSeaSeS; a Single centre exPerience
2008;41(3):222-6.
(18) Leder K, Hellard ME, Sinclair MI, 
Fairley CK, Wolfe R. No correlation 
between clinical symptoms and 
Blastocystis hominis in immuno-
competent individuals. J Gastroen-
terol Hepatol 2005;20(9):1390-4.
(19) Horiki N, Maruyama M, Fujita Y, 
Yonekura T, Minato S, Kaneda Y. 
Epidemiologic survey of Blastocys-
tis hominis infection in Japan. Am J 
Trop Med Hyg 1997;56(4):370-4.
(20) Senay H, MacPherson D. Blas-
tocystis hominis: epidemiology 
and natural history. J Infect Dis 
1990;162(4):987-90.
(21) Stensvold CR, Arendrup MC, Jes-
persgaard C, Mølbak K, Nielsen HV. 
Detecting Blastocystis using parasi-
tologic and DNA-based methods: a 
comparative study. Diagn Micro-
biol Infect Dis 2007;59(3):303-307.
(22) Suresh K, Smith H. Comparison of 
methods for detecting Blastocystis 
hominis. Eur J Clin Microbiol Infect 
Dis 2004;23(6):509-511. 
(23) Kevin SW. Tan new insights on clas-
sification, identification, and clini-
cal relevance of Blastocystis spp. 
Clin Microbiol Rev 2008;21(4):639-
665. 
(24) Hameed DM, Hassanin OM, 
Zuel-Fakkar NM. Association of 
Blastocystis hominis genetic sub-
types with urticaria. Parasitol Res 
2011;108(3):553-60.
